Wei-Hsan Chao

Title: Innovations of Wei-Hsan Chao in Optical Imaging

Introduction

Wei-Hsan Chao is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of optical imaging, particularly in the development of diagnostic agents for prostate cancer. His innovative work has the potential to enhance the accuracy of prostate cancer diagnostics.

Latest Patents

Wei-Hsan Chao holds a patent for "Prostate-specific antigen probes for optical imaging." This invention provides a novel probe that contains a prostate peptide substrate. The probe can be utilized as a prostate diagnostic agent for optical imaging. An 11 amino acid peptide substrate is synthesized for specific prostate-specific antigen (PSA). This protected graft copolymer (PGC) consists of a poly-L-lysine (PL) backbone and methoxypoly(ethylene glycol) (MPEG). Two terminals of the peptide substrate are bound to poly-L-lysine and Cy5.5 fluorochrome. This probe will be used as a NIR (near-infrared fluorescence) probe for optical imaging.

Career Highlights

Wei-Hsan Chao is affiliated with Kaohsiung Medical University, where he conducts his research and development work. His innovative approach to creating diagnostic tools has garnered attention in the medical community. He has successfully developed a patent that addresses a critical need in prostate cancer diagnostics.

Collaborations

Wei-Hsan Chao has collaborated with notable colleagues, including Jui-Sheng Hsu and Gin-Chung Liu. Their combined expertise contributes to the advancement of research in optical imaging and prostate diagnostics.

Conclusion

Wei-Hsan Chao's contributions to the field of optical imaging, particularly through his patented innovations, highlight the importance of research in improving diagnostic methods for prostate cancer. His work continues to pave the way for advancements in medical technology.